Chronic Thromboembolic Pulmonary Hypertension clinical trials

Explore recruiting chronic thromboembolic pulmonary hypertension clinical trials.

Recruiting chronic thromboembolic pulmonary hypertension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Thromboembolic Pulmonary Hypertension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicentre, Randomized Trial of Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism (PRAGUE-26)

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a randomized open label trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

STOP-RIO: A randomized controlled non-inferiority trial to test the safety of discontinuation of riociguat after balloon pulmonary angioplasty in Chronic Thrombo-embolic Pulmonary Hypertension

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

IMPACT-CTEPH Initial dual oral coMbination therapy versus standard-of-care initial oral monotherapy Prior to balloon pulmonary Angioplasty in patients with inoperable Chronic thromboembolic pulmonary hyperTension”

France

Therapeutic exploratory (Phase II) EU CTIS Study details

PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controlled trial

Netherlands, Spain, Italy, Germany, Austria, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Chronic Thromboembolic Pulmonary Hypertension trials by city

Chronic Thromboembolic Pulmonary Hypertension in Toronto Chronic Thromboembolic Pulmonary Hypertension in Vancouver Chronic Thromboembolic Pulmonary Hypertension in Montreal Chronic Thromboembolic Pulmonary Hypertension in Calgary Chronic Thromboembolic Pulmonary Hypertension in Edmonton Chronic Thromboembolic Pulmonary Hypertension in Ottawa Chronic Thromboembolic Pulmonary Hypertension in Winnipeg Chronic Thromboembolic Pulmonary Hypertension in Quebec City Chronic Thromboembolic Pulmonary Hypertension in Hamilton Chronic Thromboembolic Pulmonary Hypertension in Kitchener Chronic Thromboembolic Pulmonary Hypertension in London Chronic Thromboembolic Pulmonary Hypertension in Halifax Chronic Thromboembolic Pulmonary Hypertension in New York Chronic Thromboembolic Pulmonary Hypertension in Los Angeles Chronic Thromboembolic Pulmonary Hypertension in Chicago Chronic Thromboembolic Pulmonary Hypertension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease